Evidence map›Paper›PMID 32851372›Full record

ArticleArchives of rheumatology2020

Sarcoidosis in Jordan: A Study of the Clinical Phenotype and Disease Outcome.

Fatima Alnaimat, Khaled Al Oweidat, Anas Alrwashdeh, Ahmad Alnashrati, Saba Barham, Mohammad Hijaz, Dina Murad, Sameeha Alshelleh, Nathir Obeidat

Open access · diamondAbstract read
In one paragraph

Article in Archives of rheumatology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Observational
  2. Article
  3. Pulmonary Function in Pulmonary Sarcoidosis.Journal of clinical medicine · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Fatima AlnaimatDepartment of Internal Medicine, Division of Rheumatology, University of Jordan, Amman, Jordan.ORCID 0000-0002-5574-2939
Khaled Al OweidatDepartment of Internal Medicine, Division of Respiratory and Sleep Medicine, University of Jordan, Amman, Jordan.ORCID 0000-0001-9335-9167
Anas AlrwashdehDepartment of Internal Medicine, University of Jordan, Amman, Jordan.ORCID 0000-0002-3626-090X
Ahmad AlnashratiDepartment of Internal Medicine, University of Jordan, Amman, Jordan.ORCID 0000-0002-6615-1691
Saba BarhamDepartment of Internal Medicine, University of Jordan, Amman, Jordan.ORCID 0000-0003-3741-092X
Mohammad HijazDepartment of Internal Medicine, University of Jordan, Amman, Jordan.ORCID 0000-0001-5709-0025
Dina MuradDepartment of Internal Medicine, University of Jordan, Amman, Jordan.ORCID 0000-0003-1217-8941
Sameeha AlshellehDepartment of Internal Medicine Division of Nephrology, University of Jordan, Amman, Jordan.ORCID 0000-0003-4216-0662
Nathir ObeidatDepartment of Internal Medicine, Division of Respiratory and Sleep Medicine, University of Jordan, Amman, Jordan.ORCID 0000-0001-6520-8871
University of Jordan · JO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThis study aims to evaluate the clinical phenotypic features of sarcoidosis in a single-center academic hospital in Jordan. PATIENTS AND

methodsA retrospective file review was performed at an academic medical center in Jordan that included all patients diagnosed with sarcoidosis between January 2000 and December 2018. A total of 150 patients with sarcoidosis (38 males, 112 females; mean age 47.8±11.7 years; range, 17 to 79 years) were evaluated. Clinical data extracted from the files included the sex of the patient, the age at time of diagnosis, diagnosis date, the season during which the diagnosis was established, and smoking history. Biopsy histopathology, spirometry, nerve conduction, echocardiography, and imaging reports including plain radiographs, ultrasonographic, magnetic resonance and computed tomography reports were reviewed. Data including laboratory values, medication usage, clinical outcomes, and morbidity/mortality were collected. Pulmonary function tests including spirometry and lung volumes along with the diffusing capacity for carbon monoxide were reviewed for the presence of restriction, obstruction or reduction in the diffusion capacity of carbon monoxide. Identification of extra-thoracic organ involvement was determined in each patient in accordance with the criteria suggested by the updated World Association of Sarcoidosis and Other Granulomatous Disorders.

resultsA total of 77.3% of the patients were diagnosed by biopsy. One case of Lofgren's syndrome was identified. Of the patients, 18.0% had isolated pulmonary sarcoidosis, 75.3% had pulmonary and extra-pulmonary sarcoidosis and 6.7% had isolated extra-pulmonary sarcoidosis while 81.3% had respiratory symptoms, mostly shortness of breath and cough. Extra-thoracic organ involvement mostly involved the musculoskeletal system (33%) followed by the skin (20%). Female patients had more extra-thoracic involvement but the sex difference was only statistically significant for cutaneous involvement. Of the patients, 84% received treatment while 20% had disease remission during the first two years after diagnosis and 70% required treatment beyond two years after diagnosis.

conclusionVarious sarcoidosis clinical phenotypes are seen among Jordanian patients. Jordanian females are more affected by the disease and have more extra-thoracic involvement compared to male patients. A large number of the study patients received treatment.

Indexed as

ArabJordansarcoidosisWorld Association of Sarcoidosis and Other Granulomatous Disorders

Identifiers

PMID32851372
PMCPMC7406155
OpenAlexW3034114806

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.